Cubist Pharma (CBST) Income Statement

Click line-items for a historical chart and %

U.S. product revenues, net	291.88M
International product revenues	16.62M
Service revenues	0
Other revenues	653K
Total revenues, net	309.16M
Cost of product revenues	94.96M
Research and development	66.03M
Contingent consideration
Selling, general and administrative	77.79M
Total costs and expenses	241.35M
Operating (loss) income	67.81M
Interest income	-276K
Interest expense	14.66M
Other income (expense)	-357K
Total other income (expense), net	14.03M
(Loss) income before income taxes
(Benefit) provision for income taxes	30.95M
Net (loss) income
Basic net (loss) income per common share (in dollars per share)	0.3
Diluted net (loss) income per common share (in dollars per share)	0.29
Basic net (loss) income per common share (in shares)	75.83M
Diluted net (loss) income per common share (in shares)	86M

Entities mentioned with CBST

View All Entities